Humana forecast annual profit slightly below Wall Street estimates on Tuesday, signaling that costs from its ...
Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV vaccine there is expected to hurt 2025 revenue, but it still posted a strong ...
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...
Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...
After a slow 2024, dealmaking in the U.S. healthcare sector is picking up. Springworks has a market value of $3 billion.
Merck KGaA is in advanced talks to buy US cancer and rare diseases drugmaker SpringWorks Therapeutics Inc., according to a ...
British defence group Babcock on Thursday hiked its revenue expectations for the year to around 4.9 billion pounds ($6.11 billion), on the back of strength in its nuclear and marine segments.
EST Merck KGaA (MKGAY) in talks to buy SpringWorks Therapeutics (SWTX), Reuters reportsMaximize Your Portfolio with Data Driven ...
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
A transaction for Springworks would rank as one of the biggest pharma deals for Merck in recent years and boost its ongoing ...
German healthcare and technology group Merck KGaA (MKGAY) is in advanced talks to acquire U.S. cancer and rare disease drugmaker Springworks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results